IN2012DN03330A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03330A
IN2012DN03330A IN3330DEN2012A IN2012DN03330A IN 2012DN03330 A IN2012DN03330 A IN 2012DN03330A IN 3330DEN2012 A IN3330DEN2012 A IN 3330DEN2012A IN 2012DN03330 A IN2012DN03330 A IN 2012DN03330A
Authority
IN
India
Prior art keywords
proteins
virus
efficient manner
endoplasmic reticulum
highly efficient
Prior art date
Application number
Other languages
English (en)
Inventor
In Hwan Hwang
Eun Ju Sohn
Eun Hye Kwon
Yun Jeong Na
Eun Hyun Jeon
Se Jin Im
Ki Seok Park
Young Chul Sung
Original Assignee
Helix Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Co Ltd filed Critical Helix Co Ltd
Publication of IN2012DN03330A publication Critical patent/IN2012DN03330A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN3330DEN2012 2009-10-06 2010-10-06 IN2012DN03330A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20090094627 2009-10-06
KR1020100096488A KR101262300B1 (ko) 2009-10-06 2010-10-04 형질전환 식물 유래의 고병원성 조류독감 바이러스 단백질 백신 및 그 제조방법
PCT/KR2010/006821 WO2011043584A2 (fr) 2009-10-06 2010-10-06 Vaccin protéique contre le virus de la grippe aviaire hautement pathogène, issu de plantes transgéniques et son procédé de préparation

Publications (1)

Publication Number Publication Date
IN2012DN03330A true IN2012DN03330A (fr) 2015-10-23

Family

ID=44045255

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3330DEN2012 IN2012DN03330A (fr) 2009-10-06 2010-10-06

Country Status (6)

Country Link
US (1) US20120219580A1 (fr)
EP (1) EP2486791A4 (fr)
KR (1) KR101262300B1 (fr)
CN (1) CN102770016A (fr)
IN (1) IN2012DN03330A (fr)
WO (1) WO2011043584A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101535704B1 (ko) * 2012-12-28 2015-07-27 한국생명공학연구원 항원성 단백질 고정화를 통한 돈단독 백신 제조방법
EP2970397A2 (fr) 2013-03-14 2016-01-20 University Of Washington Through Its Center For Commercialization Polypeptides pour le traitement et/ou la limitation d'une infection grippale
KR101602562B1 (ko) * 2014-06-10 2016-03-10 포항공과대학교 산학협력단 인플루엔자 a 바이러스 h5n1의 헤마글루티닌을 발현하는 식물체 및 사포닌을 포함하는 경구용 인플루엔자 a 바이러스 h5n1 백신 조성물
CN109563518A (zh) * 2016-05-12 2019-04-02 巴伊沃爱普有限公司 来自植物的用于经典猪瘟的疫苗组合物及其制造方法
IL263416B2 (en) * 2016-06-03 2024-10-01 Sanofi Pasteur Inc Modification of transgenic influenza hemagglutinin polypeptides
CN107058377A (zh) * 2017-06-16 2017-08-18 深圳惠升生物科技有限公司 植物作为宿主在表达中东呼吸综合征的疫苗中的应用
KR102128453B1 (ko) * 2018-03-23 2020-07-01 주식회사 젠바디 황열 바이러스 유래 ns1 단백질, 이에 특이적으로 결합하는 단일클론항체 및 이의 용도
KR102138272B1 (ko) 2018-09-19 2020-07-28 주식회사 바이오앱 BiP 단편을 포함하는 재조합 벡터 및 상기 벡터를 이용한 재조합 단백질의 제조 방법
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
KR102317403B1 (ko) * 2019-01-28 2021-10-29 주식회사 바이오앱 당화된 Ag85A 단백질을 포함하는 결핵 예방용 백신 조성물 및 이의 제조방법
KR102209198B1 (ko) * 2019-04-02 2021-02-02 주식회사 바이오앱 식물에서의 발현이 최적화된 재조합 이리신 유전자 및 이를 이용한 재조합 이리신 단백질의 생산 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242518A1 (en) * 2002-09-28 2004-12-02 Massachusetts Institute Of Technology Influenza therapeutic
KR100769584B1 (ko) 2004-07-30 2007-10-23 학교법인 포항공과대학교 셀룰로오스의 자가가수분해를 위한 셀룰라아제 발현형질전환 식물체 및 이를 이용한 수용성 당의 생산방법
CU23576A1 (es) * 2006-02-28 2010-09-30 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la influenza aviar
CA2657849A1 (fr) * 2006-05-18 2008-05-08 Pharmexa Inc. Induction de reponses immunitaires au virus de la grippe en utilisant des compositions de polypeptides et d'acides nucleiques
CN1884517B (zh) * 2006-06-08 2010-06-30 武汉禾元生物科技有限公司 利用谷物非储藏蛋白为融合载体在胚乳表达多肽的方法及应用
ATE458839T1 (de) 2006-10-20 2010-03-15 3M Innovative Properties Co Verfahren für leicht zu reinigende substrate und artikel daraus
CN101284130B (zh) * 2007-04-09 2011-12-14 生宝生物科技股份有限公司 利用逆向基因工程技术开发蛋白质疫苗与禽流感疫苗的方法
KR101161622B1 (ko) * 2009-08-31 2012-07-04 헬릭스 주식회사 번역 효율 증진용 ｄｎａ 단편 및 이를 포함하는 재조합 벡터

Also Published As

Publication number Publication date
EP2486791A4 (fr) 2013-06-12
WO2011043584A9 (fr) 2011-09-01
US20120219580A1 (en) 2012-08-30
CN102770016A (zh) 2012-11-07
WO2011043584A2 (fr) 2011-04-14
EP2486791A2 (fr) 2012-08-15
KR101262300B1 (ko) 2013-05-20
WO2011043584A3 (fr) 2011-10-20
KR20110037880A (ko) 2011-04-13

Similar Documents

Publication Publication Date Title
IN2012DN03330A (fr)
NZ590351A (en) HA1 domain totally or partially free of N-linked glycosylation operatively linked to a regulatory region
PH12015502217A1 (en) Influenza virus-like particle production in plants
AR088858A1 (es) Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas
EA201001198A1 (ru) Рекомбинантные вирусоподобные частицы (вч), схожие с вирусом гриппа, производящиеся в трансгенных растениях, экспрессирующих гемагглютинин
MX2011013517A (es) Partículas similares al virus de la influenza quiméricas que comprenden hemaglutinina.
MA32439B1 (fr) Particules pseudovirales (vlp) de la grippe recombinées produites dans des plantes transgéniques exprimant l'hémagglutinine
IN2014CN02114A (fr)
NZ627796A (en) Influenza virus vaccines and uses thereof
WO2010036970A3 (fr) Vaccins contre la grippe, antigènes, compositions, et procédés
CL2017001665A1 (es) Inductor haploide
MX2011007961A (es) Determinacion de sexo y metodos de especificacion del mismo.
MX368142B (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
NZ622731A (en) Increasing virus-like particle yield in plants
SG10201405123WA (en) Recombinant avian paramyxovirus vaccine and method for making and using thereof
NZ596366A (en) Enhanced immune response in avian species
EA201300525A1 (ru) Новые вакцины против пандемичного вируса гриппа a/h1n1
ZA201106852B (en) A method to prepare inactivated vaccine for h9n2 sub-type avian influenza and product
IN2014CN01936A (fr)
MX363464B (es) Vacunas contra influenza h5.
MX2013012986A (es) Plantas que tienen uno o mas rasgos mejorados relacionados con el rendimento y un metodo para producirlas.
UA112305C2 (uk) Спосіб приготування приправочного продукту
FR2962739B1 (fr) Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza
BR112012021231A2 (pt) método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto
PH12015501132A1 (en) Improved methods for inducing apomixis in plants